Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$3.71 – $5.75
59% from low
Exchange
OTC Link
ADRC
P/S (TTM)
0.0
EV / FCF (TTM)
—
ONO PHARM CO UNSP/ADR
No one on the platform currently holds OPHLY.
No tracked institution reports a position in OPHLY as of their last filing.
| Execution date | Ratio |
|---|---|
| 2016-04-04 | 3-for-1 |
| 2014-05-29 | 5-for-1 |
No one on the platform has traded OPHLY yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 11.2% | 13.7% | 12.8% | — | — | — |
| Rev. Growth % | 12.3% | 12.1% | ||||
| Profit Margin % | 13.5% | 19.4% | 20.1% | |||
| Free Cash Flow Margin % | 25.4% | 20.9% | 16.8% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is +97.0% on the P/E track.
At today's price, your expected annual return is +97.1% on the P/E track.
At today's price, your expected annual return is +97.2% on the P/E track.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $467.1B | -9.0% | $53.14 | $50.68–$55.63 | 0.1× | 1 |
| 2028 | $454.4B | -2.7% | $45.75 | $43.63–$47.90 | 0.1× | 1 |
| 2029 | $469.3B | +3.3% | $50.71 | $48.36–$53.09 | 0.1× | 1 |
| 2030 | $482.7B | +2.9% | $51.15 | $48.78–$53.55 | 0.1× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-31 | $0.07 | $0.11 | +50.2% |
| 2026-05-08 | $0.02 | $0.00 | -78.5% |
| 2026-02-02 | $0.10 | $0.13 | +36.5% |
| 2025-10-30 | $0.09 | $0.10 | +15.1% |
| 2025-08-01 | $0.11 | $0.08 | -25.3% |
| 2025-05-08 | $0.03 | $-0.03 | -210.3% |
| 2025-02-03 | $0.09 | $0.07 | -23.5% |
| 2024-10-31 | $0.11 |
| $0.08 |
| -30.9% |
| +0.00% |
| $4.6B |
| — |
| HKMPYHikma Pharmaceuticals PLC | $41.31 | +0.00% | $4.3B | — |
| HLBBFH. Lundbeck A/S | $6.75 | +0.00% | $5.4B | — |
Source: Financial Modeling Prep · peers by sector/industry